George Millen: Unscripted

DXS International defies market headwinds, turning a profit despite NHS delays. A strengthened balance sheet and a hit new product signal a new chapter.

Unum Group's promotion of Andrew Walker isn't just a title change. It's a calculated move to place customer operations at the heart of its strategy.

As brands struggle to move AI from experiment to production, one firm is betting on a new model: embedding engineers directly into client teams.

With backing from Sharplink and Joe Lubin, the new Ethereum Institutional non-profit aims to be the definitive gateway for TradFi. But can it stay neutral?

With its acquisition of Argon Electronics, Evallic isn't just buying a company; it's completing a strategic blueprint for integrated CBRNe defence in Europe.

With a scant 5.6% shareholder turnout, Rock Tech Lithium secured a powerful mandate for a share consolidation and its ambitious transatlantic lithium strategy.

Beyond flashy ads, Taiwan is executing a masterclass in tourism strategy, blending shrewd business partnerships with deep cultural diplomacy to win over Oceania.

Inflation is the unseen threat to retirement security. A new advisory reveals why traditional savings fail and how a strategic shift toward growth is essential.

Sprocket Security's new AI agent, Apex, isn't just another tool. It signals a shift from outdated security audits to continuous, human-validated assurance.

A new FinTech platform is automating the recovery of Florida's $4 billion in unclaimed funds. Is this the key for citizens, or a new tax on bureaucracy?

Beyond a simple conference, Tsingke Biotech's recent salon was a strategic play to position itself as the linchpin in China's shift to biotech innovation.

A new partnership aims to solve AI's biggest workplace problem: its intrusiveness. By moving AI to the edge, Syntiant and Vibe promise a seamless future.

With a near-total bond buyback, QXO has cleared a major financial hurdle in its massive TopBuild acquisition, paving the way for an industry-shaping merger.

New data reveals how Genelux’s oncolytic virus reawakens chemotherapy's power, offering a potential lifeline in a notoriously difficult-to-treat cancer.

AmeriPath USA's vertically integrated model of buying, renovating, and operating recovery homes isn't just housing—it's a new asset class for social impact.

Packsize's latest acquisition of Italian firm Panotec isn't just a deal; it's a calculated move to dominate the global automated packaging market.

The iconic Italian cheese is doubling down on the U.S. with a new playbook. It’s not just about sales—it’s a sophisticated bid for cultural integration.

A new expert guide breaks down homeowners insurance, but the real story lies in the gaps. Are you prepared for the financial storms on the horizon?

Kestra Investment Management's rapid climb to $5 billion AUM reveals a powerful strategy combining model portfolio efficiency with visionary leadership.

GE's new Allia upgrade pathways offer a lifeline to hospitals, blending AI innovation with fiscal and environmental responsibility. Is this the future of MedTech?